Cormark upgraded shares of Extendicare (TSE:EXE – Free Report) to a moderate buy rating in a research note released on Wednesday,Zacks.com reports.
Several other analysts also recently issued reports on EXE. BMO Capital Markets set a C$11.00 price objective on shares of Extendicare and gave the stock a “market perform” rating in a report on Thursday, January 30th. Royal Bank of Canada lifted their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. Finally, TD Securities increased their price objective on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research report on Thursday, November 14th. Three equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Extendicare currently has a consensus rating of “Hold” and an average target price of C$10.25.
Get Our Latest Analysis on EXE
Extendicare Trading Up 2.1 %
Extendicare Announces Dividend
The firm also recently declared a monthly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 17th will be issued a $0.04 dividend. This represents a $0.48 annualized dividend and a yield of 4.15%. The ex-dividend date of this dividend is Friday, February 28th. Extendicare’s dividend payout ratio (DPR) is presently 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Read More
- Five stocks we like better than Extendicare
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.